Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Szczesniak A, Gorny B, Kowalewski M, et al. Things to avoid in meta-analysis. Eur J Prev Cardiol 2013. [Epub ahead of print 25 March 2013].

Lupi

Rognoni

Secco

. Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5834 patients. Eur J Prev Cardiol, 2012. [Epub ahead of print].

Dou

Han

. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results. Chin Med J 2011; 124: 811–816.

Windecker

Serruys

Wandel

. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 2008; 372: 1163–1173.

Rognoni

Santagostino

Sansa

. Regarding ‘Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review’. EuroIntervention 2012; 8: 642–643.

Traps and pitfalls in evaluating a meta-analysis: rebuttal to the letter by Szczesniak et al.

Abstract

Get full access to this article

References